125 related articles for article (PubMed ID: 38147900)
1. Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data.
Merola JF; Ertmer B; Liang H; Yue X; Ofori S; Krueger W
J Am Acad Dermatol; 2024 May; 90(5):935-944. PubMed ID: 38147900
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated inflammatory diseases and risk of venous thromboembolism: A Mendelian randomization study.
Lv X; Gao X; Liu J; Deng Y; Nie Q; Fan X; Ye Z; Liu P; Wen J
Front Immunol; 2022; 13():1042751. PubMed ID: 36582224
[TBL] [Abstract][Full Text] [Related]
3. Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study.
Galloway J; Barrett K; Irving P; Khavandi K; Nijher M; Nicholson R; de Lusignan S; Buch MH
RMD Open; 2020 Sep; 6(3):. PubMed ID: 32994362
[TBL] [Abstract][Full Text] [Related]
4. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study.
Ogdie A; Kay McGill N; Shin DB; Takeshita J; Jon Love T; Noe MH; Chiesa Fuxench ZC; Choi HK; Mehta NN; Gelfand JM
Eur Heart J; 2018 Oct; 39(39):3608-3614. PubMed ID: 28444172
[TBL] [Abstract][Full Text] [Related]
5. MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Charles-Schoeman C; Choy E; McInnes IB; Mysler E; Nash P; Yamaoka K; Lippe R; Khan N; Shmagel AK; Palac H; Suboticki J; Curtis JR
RMD Open; 2023 Nov; 9(4):. PubMed ID: 37945286
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.
Schneeweiss MC; Kirchgesner J; Wyss R; Jin Y; York C; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S; Glynn RJ
Br J Dermatol; 2022 Nov; 187(5):692-703. PubMed ID: 35718888
[TBL] [Abstract][Full Text] [Related]
8. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Mease P; Charles-Schoeman C; Cohen S; Fallon L; Woolcott J; Yun H; Kremer J; Greenberg J; Malley W; Onofrei A; Kanik KS; Graham D; Wang C; Connell C; Valdez H; Hauben M; Hung E; Madsen A; Jones TV; Curtis JR
Ann Rheum Dis; 2020 Nov; 79(11):1400-1413. PubMed ID: 32759265
[TBL] [Abstract][Full Text] [Related]
9. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Rubin DT; Mittal M; Davis M; Johnson S; Chao J; Skup M
J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
[TBL] [Abstract][Full Text] [Related]
10. The risk of venous thromboembolism in atopic dermatitis: a matched cohort analysis in UK primary care.
Warren RB; Basey V; Lynam A; Curtis C; Ardern-Jones MR
Br J Dermatol; 2023 Sep; 189(4):427-436. PubMed ID: 37418627
[TBL] [Abstract][Full Text] [Related]
11. Risk of Venous Thromboembolism Among Adults With Atopic Dermatitis.
Chen TL; Huang WT; Loh CH; Huang HK; Chi CC
JAMA Dermatol; 2023 Jul; 159(7):720-727. PubMed ID: 37256633
[TBL] [Abstract][Full Text] [Related]
12. The association between psoriatic arthritis and venous thromboembolism: a population-based cohort study.
Gazitt T; Pesachov J; Lavi I; Elias M; Haddad A; Feldhamer I; Cohen AD; Saliba W; Zisman D
Arthritis Res Ther; 2022 Jan; 24(1):16. PubMed ID: 34996505
[TBL] [Abstract][Full Text] [Related]
13. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
[TBL] [Abstract][Full Text] [Related]
14. Venous Thromboembolism After COVID-19 Infection Among People With and Without Immune-Mediated Inflammatory Diseases.
Khan R; Kuenzig ME; Tang F; Im JHB; Widdifield J; McCurdy JD; Kaplan GG; Benchimol EI
JAMA Netw Open; 2023 Oct; 6(10):e2337020. PubMed ID: 37812417
[TBL] [Abstract][Full Text] [Related]
15. Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study.
de Lusignan S; Alexander H; Broderick C; Dennis J; McGovern A; Feeney C; Flohr C
J Allergy Clin Immunol; 2022 Sep; 150(3):709-713. PubMed ID: 35469843
[TBL] [Abstract][Full Text] [Related]
16. Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.
Fujiya M; Kawaguchi T; Arai S; Isogawa N; Hiro S; Matsumoto F; Yamaguchi S; Yoshii N; Nakamura M; Matsuoka K
Dig Dis Sci; 2022 Nov; 67(11):5195-5205. PubMed ID: 35150345
[TBL] [Abstract][Full Text] [Related]
17. Risk of Inflammatory Bowel Disease in Patients With Atopic Dermatitis.
Chiesa Fuxench ZC; Wan J; Wang S; Syed MN; Shin DB; Abuabara K; Gelfand JM
JAMA Dermatol; 2023 Oct; 159(10):1085-1092. PubMed ID: 37647058
[TBL] [Abstract][Full Text] [Related]
18. Effects of immune-mediated inflammatory diseases on cardiovascular diseases in patients with type 2 diabetes: a nationwide population-based study.
Kwon OC; Han K; Chun J; Kim R; Hong SW; Kim JH; Youn YH; Park H; Park MC;
Sci Rep; 2022 Jul; 12(1):11548. PubMed ID: 35798796
[TBL] [Abstract][Full Text] [Related]
19. Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials.
Schreiber S; Colombel JF; Feagan BG; Reich K; Deodhar AA; McInnes IB; Porter B; Das Gupta A; Pricop L; Fox T
Ann Rheum Dis; 2019 Apr; 78(4):473-479. PubMed ID: 30674475
[TBL] [Abstract][Full Text] [Related]
20. Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
McCurdy JD; Kuenzig ME; Smith G; Spruin S; Murthy SK; Carrier M; Nguyen GC; Benchimol EI
Inflamm Bowel Dis; 2020 Oct; 26(11):1761-1768. PubMed ID: 31995204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
